Suppr超能文献

经皮给药系统应用后尼古丁的生物利用度及吸收动力学

Bioavailability and absorption kinetics of nicotine following application of a transdermal system.

作者信息

Gupta S K, Benowitz N L, Jacob P, Rolf C N, Gorsline J

机构信息

ALZA Corporation, Palo Alto, California 94304, USA.

出版信息

Br J Clin Pharmacol. 1993 Sep;36(3):221-7. doi: 10.1111/j.1365-2125.1993.tb04221.x.

Abstract
  1. The absolute bioavailability and absorption kinetics of nicotine were investigated in 13 healthy adult male smokers following single and multiple applications of a nicotine transdermal system (NTS), designed to release nicotine at an approximate rate of 1.5 mg h-1 over 24 h. The absorption of nicotine from the single NTS application was calculated with reference to a simultaneous intravenous infusion (i.v.) of deuterium-labelled nicotine. 2. The mean input time (MIT) and mean absorption time (MAT) for nicotine following application of NTS for 24 h were 7.7 and 4.2 h, respectively. 3. Following NTS removal, the mean apparent nicotine elimination half-life was 2.8 h, compared with 2.0 h following i.v. nicotine, reflecting continued absorption of nicotine following NTS removal. 4. The mean amount of nicotine absorbed from the NTS after the 24 h application was 20.9 mg, which represents about 68% of the amount released from the system; the remaining 32% was lost from the system during daily activities. 5. The ratio of AUC values for the metabolite cotinine relative to nicotine was similar whether nicotine was administered transdermally or intravenously. 6. Following i.v. administration, the mean nicotine clearance was 72 l h-1 (coefficient of variation 29%). Since coefficients of variation in AUC values following NTS and i.v. treatments were similar, transdermal administration of nicotine was not associated with increased interindividual variability in plasma nicotine concentrations. 7. No significant changes were seen in the pharmacokinetics of nicotine between single and multiple applications of NTS. 8. As expected from the higher total plasma nicotine concentrations, the incidence of adverse effects was higher following simultaneous intravenous and transdermal administration of nicotine. The most frequently reported systemic side effects were nervousness and headache: mild itching was the most frequent topical effect.
摘要
  1. 在13名健康成年男性吸烟者中,对尼古丁透皮系统(NTS)单次和多次应用后尼古丁的绝对生物利用度和吸收动力学进行了研究,该系统设计为在24小时内以约1.5毫克/小时的速率释放尼古丁。单次应用NTS后尼古丁的吸收量是参照同时静脉输注氘标记尼古丁来计算的。2. 应用NTS 24小时后,尼古丁的平均输入时间(MIT)和平均吸收时间(MAT)分别为7.7小时和4.2小时。3. 去除NTS后,尼古丁的平均表观消除半衰期为2.8小时,而静脉注射尼古丁后为2.0小时,这反映了去除NTS后尼古丁仍在持续吸收。4. 应用NTS 24小时后,从NTS吸收的尼古丁平均量为20.9毫克,约占系统释放量的68%;其余32%在日常活动中从系统中损失。5. 无论尼古丁是经皮给药还是静脉给药,代谢物可替宁相对于尼古丁的AUC值之比相似。6. 静脉给药后,尼古丁的平均清除率为72升/小时(变异系数29%)。由于NTS和静脉给药治疗后AUC值的变异系数相似,经皮给药尼古丁与血浆尼古丁浓度个体间变异性增加无关。7. NTS单次和多次应用之间,尼古丁的药代动力学未见显著变化。8. 正如较高的总血浆尼古丁浓度所预期的那样,同时静脉和经皮给药尼古丁后不良反应的发生率更高。最常报告的全身副作用是紧张和头痛:轻度瘙痒是最常见的局部效应。

相似文献

2
Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.
J Clin Pharmacol. 1995 Oct;35(10):985-9. doi: 10.1002/j.1552-4604.1995.tb04014.x.
3
Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
J Clin Pharmacol. 1993 Feb;33(2):169-74. doi: 10.1002/j.1552-4604.1993.tb03939.x.
5
Pharmacokinetic disposition of multiple-dose transdermal nicotine in healthy adult smokers.
Pharm Res. 1992 Nov;9(11):1451-5. doi: 10.1023/a:1015862930096.

引用本文的文献

4
Nicotinic receptor modulation of the default mode network.烟碱型乙酰胆碱受体对默认模式网络的调制。
Psychopharmacology (Berl). 2021 Feb;238(2):589-597. doi: 10.1007/s00213-020-05711-9. Epub 2020 Nov 20.
5
Effects of smoking cessation on biological monitoring markers in urine.戒烟对尿液中生物监测标志物的影响。
Genes Environ. 2020 Sep 11;42:26. doi: 10.1186/s41021-020-00165-z. eCollection 2020.
9
Systemic Toxicity of Smokeless Tobacco Products in Mice.无烟烟草制品对小鼠的系统毒性。
Nicotine Tob Res. 2019 Jan 1;21(1):101-110. doi: 10.1093/ntr/ntx230.

本文引用的文献

1
Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
J Clin Pharmacol. 1993 Feb;33(2):169-74. doi: 10.1002/j.1552-4604.1993.tb03939.x.
6
Drug accumulation.
J Clin Pharmacol J New Drugs. 1967 Mar-Apr;7(2):84-8. doi: 10.1002/j.1552-4604.1967.tb00290.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验